MIAP410: The Novel Molecule Targeting CD47/IAP for Rodent and Patient Research Groundbreaking work has MIAP410, the highly developed molecule, selectively targets the CD47-IAP structure. The promising approach presents https://www.targetmol.com/compound/anti-mouse-rat-human-cd47-iap-antibody-miap410